BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21158181)

  • 1. [Effective treatment of depression. Early reduction of painful concomitant symptoms increases the probability of remission].
    Ameri AA
    MMW Fortschr Med; 2010 Nov; 152(44):78-9. PubMed ID: 21158181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interview with Dr. Armin Spingler. Management of depression in family practice].
    Spingler A
    MMW Fortschr Med; 2010 Nov; 152(44):79. PubMed ID: 21158182
    [No Abstract]   [Full Text] [Related]  

  • 3. [Because depression also hurts: duloxetine can help patients return to vitality].
    MMW Fortschr Med; 2011 Apr; 153(14):76-7. PubMed ID: 21966877
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
    Howland RH; Wilson MG; Kornstein SG; Clayton AH; Trivedi MH; Wohlreich MM; Fava M
    Ann Clin Psychiatry; 2008; 20(4):209-18. PubMed ID: 19034753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dual mechanism of action. Remission of physical symptoms].
    MMW Fortschr Med; 2005 May; 147 Spec No 2():87. PubMed ID: 15968881
    [No Abstract]   [Full Text] [Related]  

  • 7. A word of caution about the implied role for duloxetine in pain management.
    Leo RJ
    J Clin Psychiatry; 2003 Oct; 64(10):1270. PubMed ID: 14658982
    [No Abstract]   [Full Text] [Related]  

  • 8. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders.
    Gupta S; Nihalani N; Masand P
    Ann Clin Psychiatry; 2007; 19(2):125-32. PubMed ID: 17612852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interview with Dr. Heike-Ariane Washeim, Zirndorf, and Dr. Heiner Buschmann, Übach-Palenberg (interview by Abdol A. Ameri)].
    Washeim HA; Buschmann H
    MMW Fortschr Med; 2011 Apr; 153(14):77. PubMed ID: 21966878
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychiatry benefits from psychopathology and diagnosis in shaping clinical management.
    Libiger J
    Curr Opin Psychiatry; 2007 May; 20(3):202-3. PubMed ID: 17415067
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of depression in the presence of pain symptoms.
    Mohr P; Bitter I; Svestka J; Seifritz E; Karamustafalioglu O; Koponen H; Sartorius N
    Psychiatr Danub; 2010 Mar; 22(1):4-13. PubMed ID: 20305585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of psychological symptoms and physical symptoms of depression. Rapid re-integration of patients into employment].
    MMW Fortschr Med; 2005 May; 147 Spec No 2():86. PubMed ID: 15968880
    [No Abstract]   [Full Text] [Related]  

  • 13. Time course of depression-symptom improvement during treatment with duloxetine.
    Hirschfeld RM; Mallinckrodt C; Lee TC; Detke MJ
    Depress Anxiety; 2005; 21(4):170-7. PubMed ID: 16035056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body dysmorphic disorder treated with bupropion: cases report.
    Nardi AE; Lopes FL; Valença AM
    Aust N Z J Psychiatry; 2005; 39(1-2):112. PubMed ID: 15660717
    [No Abstract]   [Full Text] [Related]  

  • 15. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence and predictors of pain in depression: results from the FINDER study.
    Demyttenaere K; Reed C; Quail D; Bauer M; Dantchev N; Montejo AL; Monz B; Perahia D; Tylee A; Grassi L
    J Affect Disord; 2010 Sep; 125(1-3):53-60. PubMed ID: 20188422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis.
    Spielmans GI
    Psychother Psychosom; 2008; 77(1):12-6. PubMed ID: 18087203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe depression : pharmacological treatments].
    Mouchabac S
    Encephale; 2009 Dec; 35 Suppl 7():S319-24. PubMed ID: 20141796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is duloxetine effective treatment for depression with atypical features?
    Stewart JW; Deliyannides DA; McGrath PJ
    Int Clin Psychopharmacol; 2008 Nov; 23(6):333-6. PubMed ID: 18854721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER.
    Reed C; Monz BU; Perahia DG; Gandhi P; Bauer M; Dantchev N; Demyttenaere K; Garcia-Cebrian A; Grassi L; Quail D; Tylee A; Montejo AL
    J Affect Disord; 2009 Mar; 113(3):296-302. PubMed ID: 18603303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.